Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02335333 · ClinicalTrials.gov registry record
Biomarkers of Aging as Predictors of Kidney Transplant Function
A clinical trial, sponsored by Sapere Bio.
- Completed
- Registry status
- 35
- Enrollment target
NCT02335333 is a clinical trial that has completed, run by Sapere Bio. The registered enrollment target is 35 participants.
The verdict
NCT02335333 has completed, sponsored by Sapere Bio.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The primary purpose of this study is to measure the correlation between baseline expression of aging biomarkers, SenesceTest in blood of organ donor and renal graft function. This pilot study will study patients who are undergoing renal transplantation with organs from extended criteria donors, standard criteria donors or donation after cardiac death and compare ability of SenesceTest to predict renal graft function immediately after the transplant and at 1 year followup.
Interventions
- OTHER No treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02335333
The ClinicalTrials.gov registry entry for NCT02335333 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sapere Bio, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment is the first listed.
NCT02335333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02335333 about?
NCT02335333 is a clinical study titled "Biomarkers of Aging as Predictors of Kidney Transplant Function". The primary purpose of this study is to measure the correlation between baseline expression of aging biomarkers, SenesceTest in blood of organ donor and renal graft function. This pilot study will study patients who are undergoing renal transplantation with organs from extended criteria donors, stan...
What is the current status of trial NCT02335333?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2015-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02335333?
The interventions under investigation include: No treatment (OTHER).
Who is sponsoring clinical trial NCT02335333?
This trial is sponsored by Sapere Bio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.